Winners will receive human biospecimens and support for pilot studies in kidney, cardiovascular, and respiratory diseases, as well as osteoarthritis and chronic pain The National Disease Research Interchange (NDRI) has announced the fourth cohort of winners of its...
The dGTEx projects are a huge step forward in the understanding and treatment of childhood disease The National Disease Research Interchange (NDRI) is proud to share that its Developmental Genotype Tissue Expression (dGTEx) project team has published an article on...
The National Disease Research Interchange (NDRI) is proud to announce that its Biorepository has been awarded re-accreditation from the College of American Pathologists (CAP), based on results of a recent on-site inspection conducted by CAP inspectors. Recognized for...
NAMs are a focus of the NIH and NDRI National Disease Research Interchange (NDRI)’s Thomas Bell, MS, PhD, recently served on the Organizing Committee of the “Advancing Research Infrastructure to Study Human Diseases” virtual workshop. This two-day workshop, presented...
Designation acknowledges NDRI’s sustained commitment to building thriving teams and a strong workplace culture National Disease Research Interchange (NDRI) has been recognized as a 2026 Quantum Certified Workplace™ in Philadelphia, a designation awarded to...
This initiative aims to help researchers develop more successful treatments for childhood diseases The National Disease Research Interchange (NDRI) is proud to announce that the Developmental Genotype Tissue Expression (dGTEx) project, a groundbreaking study of...
Winners will receive human biospecimens and support for pilot studies in Crohn’s Disease, diabetes, and pulmonary diseases The National Disease Research Interchange (NDRI) has announced the third cohort of winners of its Pilot Award Program: Yoko Ambrosini, DVM, MPVM,...
The National Disease Research Interchange (NDRI) is proud to congratulate Board Member Arthur Rubenstein, MBBCh, on receiving Research!America’s Herbert Pardes Family Award for National Leadership in Advocacy for Research. This award recognizes individuals who have...
First-in-human trial demonstrates the safety and feasibility of a heart-targeted AAV gene therapy, with key molecular validation supported by NDRI-sourced human tissue. Cardiotropic AAV Gene Therapy for Heart Failure: A Phase 1 Trial Authors: Timothy D. Henry, Eugene...
Study supported by NDRI-sourced, generously donated, human tissue, identifies a potential treatment that preserves vision in Diabetic Retinal Disease Scavenging Acrolein with 2-HDP Preserves Neurovascular Integrity in Diabetic Retinal Disease Authors: Josy Augustine,...
Widespread tissue distribution of transcriptionally active, clonally expanded HIV-1 proviruses despite suppressive antiretroviral therapy Hiromi Imamichi, Ven Natarajan, Francesca Scrimieri, Mindy Smith, Yunden Badralmaa, Marjorie Bosche, Jack Hensien, Thomas...
The National Disease Research Interchange (NDRI) has announced the second cohort of winners of its Pilot Award Program: Amanadine Chaix, PhD; Lily Cheng, MD; Fatima Fattahi, PhD; Keren Hilgendorf, PhD; Stanislovas Jankauskas, PhD; Frank Ko, PhD; Yun Rose Li, MD, PhD;...
The National Disease Research Interchange (NDRI) has elected Marianne Henderson, MS, CPC, ELI-MP, PMP, to its Board of Directors. Henderson is the Senior Advisor, Division Resources, of the National Cancer Institute’s Division of Cancer Epidemiology and Genetics...
NDRI joins call urging U.S. House and Senate Appropriations Committee Leadership to stand against the dramatic cuts to NIH funding proposed in the President’s 2026 budget. The letter has been signed by more than 500 organizations including national and local patient...
The National Disease Research Interchange (NDRI) has launched the National Hearing and Balance Organ Donor Program (NHBODP) through an administrative supplement grant from the National Institutes of Health’s (NIH) National Institute on Deafness and Communication...
The National Disease Research Interchange (NDRI) has announced that its Human Tissues and Organs for Research Resource (HTORR) program is participating in the Research Resource Identification (#RRID) Initiative. This initiative is designed to help researchers cite the...
The National Disease Research Interchange (NDRI), a world leader in the procurement and distribution of biospecimens to advance research, has announced the promotion of Patrick Van Hoose, PhD, to the role of Director, NIH Initiatives. Dr. Van Hoose has served as...
The National Disease Research Interchange (NDRI), a world leader in the procurement and distribution of biospecimens to advance research, has announced the promotion of Valerie J. Estela-Pro, PhD, to the role of Director, External Scientific Affairs. Dr. Estela-Pro...
NDRI joins call urging U.S. House and Senate Appropriations Committee Leadership to increase funding for the National Institutes of Health (NIH) and to preserve provisions which prevent the Department of Health and Human Services (HHS) from making abrupt changes to...
The National Disease Research Interchange (NDRI) has announced the first cohort of winners of its Pilot Award Program: Henrique Borges da Silva, Ph.D.; Paul O’Connor, Ph.D.; Eric T. Oliver, MD; and Spencer Szczesny, Ph.D. Launched in 2024, the Pilot Award Program...
The dGTEx projects are a huge step forward in the understanding and treatment of childhood disease The January 2025 issue of Nature includes an article on the NIH-funded dGTEx projects, titled “The Human and Non-human Primate Developmental GTEx Projects.” It outlines...
The National Disease Research Interchange (NDRI) has been included in the Philadelphia Business Journal’s annual Book of Lists, as one of the largest National Institutes of Health (NIH) funding recipients in the Philadelphia area (FY 2024). NDRI ranks 14th on the...
The National Disease Research Interchange (NDRI) has elected Richard D. Hasz, Jr., MFS, CPTC, to its Board of Directors. Hasz is the President and CEO of the Gift of Life Donor Program, one of the oldest and largest organ procurement organizations (OPOs) in the United...
November 13, 2024 – The National Disease Research Interchange (NDRI) is proud to announce that Pennsylvania Governor Josh Shapiro has reappointed NDRI President & CEO Bill Leinweber to the Commonwealth of Pennsylvania’s Organ Donation Advisory Committee. Leinweber...
The National Disease Research Interchange (NDRI) is pleased to welcome Anne Lotz Voorhees as its new Director of Marketing and Communications. Voorhees brings substantial experience in professional services marketing and will be responsible for leading and refining...
The Accreditation Committee of the College of American Pathologists (CAP) awarded accreditation to the National Disease Research Interchange (NDRI)’s Biorepository based on results of a recent on-site inspection conducted by CAP inspectors. The inspection team...
We're excited to share that NDRI will be exhibiting at AOPO 2024 from June 24 to June 26 in San Antonio, Texas! NDRI (National Disease Research Interchange) is a leading source of human organs and tissue for researchers around the world. NDRI partners with OPOs to...
We're excited to share that NDRI will be exhibiting at ATS 2024 from May 19 to May 21 in San Diego, California! The American Thoracic Society is the world's leading medical society dedicated to accelerating the advancement of global respiratory health through...
We're happy to share that NDRI will be exhibiting at SOT 2024 from March 10 to March 14 in Salt Lake City, UT! The Society of Toxicology (SOT) is a professional and scholarly organization of scientists from academic institutions, government, and industry representing...
The National Disease Research Interchange (NDRI) is pleased to announce its recovery network and program manager for the Somatic Mosaicism across Human Tissues (SMaHT) Tissue Procurement Center. The SMaHT Network is an NIH Common Fund initiative that will provide the...
Congratulations to Emilie Hattrell who was recently awarded Employee of the Quarter! Emilie is a recent graduate of the University of Sciences in Philadelphia with a B.S. in Biochemistry. She’s a Program Technician for the Developmental Genotype-Tissue Expression...
We’re excited to announce that NDRI will be attending NATCO’s 49th Annual Meeting from February 25 to February 28 in San Antonio, Texas. NATCO (The Organization for Donation and Transplant Professionals) is a nonprofit organization that is committed to the advancement...
The National Disease Research Interchange (NDRI) is pleased to welcome Tom Malecki as its new Chief Financial Officer and Vice President of Administration. Malecki brings a wealth of experience and has a proven track record in financial leadership across several...
The National Disease Research Interchange (NDRI) has been awarded $3.7M by the National Institutes of Health (NIH) to support continued national leadership with the recovery and distribution of human organs and tissues for medical research. This new three-year award...
The National Disease Research Interchange (NDRI) has appointed Dr. Deanne Taylor, Ph.D. to its Board of Directors. Dr. Taylor is the Scientific Director at the Department of Biomedical and Health Informatics at The Children's Hospital of Philadelphia (CHOP) and...
The National Disease Research Interchange (NDRI), a world leader in the procurement and distribution of biospecimens to advance research, announces the promotion of Thomas J. Bell, PhD, to the role of Chief Scientific Officer (CSO), and Melissa VonDran, PhD, to Senior...
Bill Leinweber, NDRI President and CEO, was recently elected to the Association of Organ Procurement Organizations (AOPO) Foundation Board of Directors. The newly formed AOPO Foundation is a 501(c)3 organization dedicated to advancing research in...
The American Thoracic Society (ATS) is a nonprofit organization focused on improving care for pulmonary diseases, critical illnesses, and sleep-related breathing disorders. Each year, they host an international conference for pulmonary, critical care, and sleep...
We’re excited to announce that NDRI will be attending ARVO 2023 from April 23 to April 26 in New Orleans, Louisiana! ARVO (The Association for Research in Vision and Ophthalmology) is the largest eye and vision research organization in the world with more than 10,000...
A recent study that included NDRI-sourced tissue to examine how Alzheimer’s disease affects the retina has been featured in a segment on CNN health. The study, lead by Dr. Maya Koronyo-Hamaoui, a professor of neurosurgery and biomedical sciences at Cedars-Sinai in Los...
NDRI's Fulfillment team For over 40 years, NDRI has provided human tissues and organs to researchers at top universities, hospitals, and medical research centers across the United States and internationally. To do this, NDRI works with a nationwide network of...
To this day, virtually every facet of the United States scientific research community remains underrepresented. The National Institutes of Health (NIH) believes that fostering a diverse workplace is key to the advancement of scientific research. Teams with individuals...
Ru-Rong Ji is a distinguished Professor of Anesthesiology and Neurobiology at Duke University. His team conducts molecular, cellular, and electrophysiological studies on human dorsal root ganglion (DRG) neurons using NDRI-supplied tissues.
The National Disease Research Interchange (NDRI), in collaboration with the University of Maryland School of Medicine and Johns Hopkins All Children’s Hospital, has been awarded a research grant of $14.4M by the National Institutes of Health (NIH) with a goal to...
At our September Service to Science Awards Dinner, the Empowering Research and Discovery Award was presented to Katalin Kariko, PhD and Dr. Drew Weissman. Dr. Kariko and Dr. Weissman, the scientists who led the research and technology development for the therapeutic...
At our 2022 Service to Science Awards Dinner in September NDRI awarded the Legacy Partnership Award to Gift of Life Donor Program of Philadelphia. They are the nation's leading organ procurement organization and coordinate more organ and tissue donors than anywhere...
NDRI celebrated researchers and partners at our Service to Science Awards Dinner. We were privileged to present the Excellence in Research and Patient Advocacy Award to David Fajgenbaum, MD, MBA, MSc, Assistant Professor in the Division of Translational Medicine &...
NDRI celebrated researchers and partners at our Service to Science Awards Dinner on Wednesday, September 28, 2022, at the Union League in Philadelphia. We were thrilled to have the opportunity to recognize researchers, partners, and organizations advancing biomedical...
NDRI is looking forward to a full year of exhibiting/attending meetings and conferences to connect with researchers and partners. Stop by our booth and let’s discuss how we can best help you with your human tissue and organ needs for research. 2023 Conference...
Dana Rosales, Director Fulfillment When a call comes in to NDRI’s Fulfillment Center from a tissue bank, eye bank or organ procurement organization, it usually signals heartache for a family. Yet it’s also a beautiful sound of hope for countless patients and their...
Victoria Corbit, PhD, Director, Scientific Services As NDRI’s new director of Scientific Services, Victoria Corbit, PhD, relies on her own unique perspective from years conducting research at top-tier universities to understand what scientists need and value from NDRI...
Saboor Shad, Director of Tissue Source Site Management at NDRI with Immanuel Rasool, Manager of Research and Living Donation at Washington Regional Transplant Community and Matthew Niles, Director of Clinical Services, Washington Regional Transplant Community Earlier...
NDRI has successfully completed the Human Tissue and Organs for Research Resource (HTORR) Autism Spectrum Disorder Brain Recovery Program. We are proud of what we have accomplished over the last seven year of participation with our Human Tissue and Organs for Research...
NDRI was recently featured in the NIH Office of Research Infrastructure Programs (ORIP) Biological Materials and Reagents Fact Sheet and on the ORIP website. The content featured our partnership with The National Institutes of Health (NIH). For over 30 years NDRI has...
Dr Hal Broxmeyer contributed many of those good days to being a tireless advocate of NDRI’s mission, as a board member for more than twenty years, and eventually board chair.
Meghan Bradshaw has been a frontline advocate for people like herself living with Lyme disease.
NDRI is proud to announce that it has received the CAP Laboratory Accreditation from the Accreditation Committee of the College of American Pathologists.
Paul M. Lieberman, Ph.D., the Hilary Koprowski, M.D., Endowed Professor, has joined the NDRI Board of Directors.
The prestigious journal Biopreservation and Biobanking paid tribute to NDRI’s 40th anniversary by publishing a commentary, “Sculpting the Future of BioBanking Base by Base”
We are proud to announce a sixth year of participation with an HTORR supplemental grant renewal for our partnership with the National Institutes of Health (NIH) Neurobiobanks.
An average of 150 publications per year are published by investigators who receive tissue from NDRI. Investigator publications cover a broad spectrum of research areas, including cancer, diabetes, cardiovascular, musculoskeletal, neuroscience, and respiratory research.
The dGTEx project will establish the first comprehensive public resource correlating gene expression and genetic variation in pediatric tissues from all major organ systems in the human body.
2022 Service to Science Awards Recipients Announced